Kalogon, Inc. — SEC Form D Filing

Kalogon, Inc. filed an SEC Form D on June 23, 2026, reporting $5.75M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
June 23, 2026
Amount reported
$5.75M
Industry
Medical Devices
Website
https://www.kalogon.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

People who must sit for extended periods experience stresses and health issues. Kalogon aims to eliminate these stresses and improve overall health for constant sitters.

Solution

Kalogon develops advanced, novel seating solutions and smart seating technologies designed to enhance comfort, protect health, and improve outcomes for individuals who need to sit for long durations.

Verdict

Investors backed this medical device play because of the clear and immediate need for pressure injury prevention in an aging population with chronic conditions, not because of a disruptive technological leap in materials science. The implicit bet was on market adoption driven by healthcare cost savings and improved patient outcomes. Upside was limited by the specialized niche and the established, albeit less technologically advanced, competitive landscape, which confined the addressable market to clinical settings rather than broader consumer adoption.

Source: SEC EDGAR Form D filing